Amidon, Gordon L.

A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability

Amidon, G. L., Lennernäs, H., Shah, V. P., & Crison, J. R. (1995) · Pharmaceutical Research

Drug Solubulity and Delivery SystemsAdvanced Drug Delivery Systems

Cited by 5,430

Dissolution Testing as a Prognostic Tool for Oral Drug Absorption: Immediate Release Dosage Forms

Dressman, J. B., Amidon, G. L., Reppas, C., & Shah, V. P. (1998) · Pharmaceutical Research

Drug Solubulity and Delivery SystemsAdvanced Drug Delivery Systems

Cited by 1,097

The Mechanism of Uptake of Biodegradable Microparticles in Caco-2 Cells Is Size Dependent

Desai, M. P., Labhasetwar, V., Walter, E., Levy, R. J., & Amidon, G. L. (1997) · Pharmaceutical Research

Advanced Drug Delivery SystemsNanoparticle-Based Drug Delivery

Cited by 858

Quantification of Gastrointestinal Liquid Volumes and Distribution Following a 240 mL Dose of Water in the Fasted State

Mudie, D. M., Murray, K., Hoad, C. L., Pritchard, S. E., Garnett, M. C., Amidon, G. L., Gowland, P. A., Spiller, R. C., Amidon, G. E., & Marciani, L. (2014) · Molecular Pharmaceutics

Drug Solubulity and Delivery SystemsGastrointestinal motility and disorders

Cited by 486

The Solubility–Permeability Interplay: Mechanistic Modeling and Predictive Application of the Impact of Micellar Solubilization on Intestinal Permeation

Miller, J. M., Beig, A., Krieg, B. J., Carr, R. A., Borchardt, T. B., Amidon, G. E., Amidon, G. L., & Dahan, A. (2011) · Molecular Pharmaceutics

Drug Solubulity and Delivery SystemsSurfactants and Colloidal Systems

Cited by 204

G.L. Amidon, H. Lennernas, V.P. Shah, and J.R. Crison. A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of In Vitro Drug Product Dissolution and In Vivo Bioavailability, Pharm Res 12, 413–420, 1995—Backstory of BCS

Shah, V. P., & Amidon, G. L. (2014) · The AAPS Journal

Drug Solubulity and Delivery SystemsAdvanced Drug Delivery Systems

Cited by 150

The BCS, BDDCS, and Regulatory Guidances

Chen, M.-L., Amidon, G. L., Benet, L. Z., Lennernas, H., & Yu, L. X. (2011) · Pharmaceutical Research

Pharmaceutical studies and practicesHealthcare Regulation

Cited by 93

Bioequivalence of Oral Products and the Biopharmaceutics Classification System: Science, Regulation, and Public Policy

Amidon, K. S., Langguth, P., Lennernäs, H., Yu, L., & Amidon, G. L. (2011) · Clinical Pharmacology & Therapeutics

Drug Solubulity and Delivery SystemsPharmaceutical Economics and Policy

Cited by 44

CHO/hPEPT1 cells overexpressing the human peptide transporter (hPEPT1) as an alternative in vitro model for peptidomimetic drugs

Han, H.-K., Rhie, J. K., Oh, D.-M., Saito, G., Hsu, C.-P., Stewart, B. H., & Amidon, G. L. (1999) · Journal of Pharmaceutical Sciences

Drug Transport and Resistance MechanismsAmino Acid Enzymes and Metabolism

Cited by 42

Mechanistic Fluid Transport Model to Estimate Gastrointestinal Fluid Volume and Its Dynamic Change Over Time

Yu, A., Jackson, T., Tsume, Y., Koenigsknecht, M., Wysocki, J., Marciani, L., Amidon, G. L., Frances, A., Baker, J. R., Hasler, W., et al. (2017) · The AAPS Journal

Gastrointestinal motility and disordersDrug Solubulity and Delivery Systems

Cited by 30